Profil
Mark McDonnell currently works as a Chief Chemist at Neuropathix, Inc.
Postes actifs de Mark McDonnell
| Sociétés | Poste | Début |
|---|---|---|
| NEUROPATHIX, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
8
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Neuropathix, Inc.
 Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Neuropathix, Inc. is a biopharmaceutical company. It engages in the research and development of novel new therapeutic agents designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis in 2010 and is headquartered in Doylestown, PA. | Health Technology |
